Cargando…

MiRNA-mediated EMT and CSCs in cancer chemoresistance

Cancer stem cells (CSCs) are a small group of cancer cells, which contribute to tumorigenesis and cancer progression. Cancer cells undergoing epithelial-to-mesenchymal transition (EMT) acquire the chemoresistant ability, which is regarded as an important feature of CSCs. Thus, there emerges an opini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Bing, Li, Shiyu, Zhu, Shuangli, Yi, Ming, Luo, Suxia, Wu, Kongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881653/ https://www.ncbi.nlm.nih.gov/pubmed/33579377 http://dx.doi.org/10.1186/s40164-021-00206-5

Ejemplares similares

EMT, CTCs and CSCs in tumor relapse and drug-resistance
por: Mitra, Abhisek, et al.
Publicado: (2015)

The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction
por: Li, Shiyu, et al.
Publicado: (2020)

The roles of exosomes in cancer drug resistance and its therapeutic application
por: Li, Shiyu, et al.
Publicado: (2020)

Clinical significance of the expression of miRNA-21, miRNA-31 and miRNA-let7 in patients with lung cancer
por: Wang, Sheng, et al.
Publicado: (2019)

OCT4B1 Promoted EMT and Regulated the Self-Renewal of CSCs in CRC: Effects Associated with the Balance of miR-8064/PLK1
por: Zhou, Jun-min, et al.
Publicado: (2019)

Cancer stem cells (CSCs), cervical CSCs and targeted therapies
por: Huang, Ruixia, et al.
Publicado: (2016)

Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis
por: Nogueras Pérez, Raquel, et al.
Publicado: (2023)

Roles of Microvesicles in Tumor Progression and Clinical Applications
por: Zhu, Shuangli, et al.
Publicado: (2021)

Pancreatic CSCs and microenvironment
por: Ilmer, Matthias, et al.
Publicado: (2015)

Correction to: Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
por: Zhu, Shuangli, et al.
Publicado: (2022)

Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
por: Zhu, Shuangli, et al.
Publicado: (2021)

Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for Neuroblastoma
por: Buhagiar, Alfred, et al.
Publicado: (2015)

RDGN-based predictive model for the prognosis of breast cancer
por: Dong, Bing, et al.
Publicado: (2020)

Upregulation of STAT1-CCL5 axis is a biomarker of colon cancer and promotes the proliferation of colon cancer cells
por: Niu, Mengke, et al.
Publicado: (2020)

Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
por: Qin, Shuang, et al.
Publicado: (2023)

Identification of miRNAs contributing to neuroblastoma chemoresistance
por: Ayers, Duncan, et al.
Publicado: (2015)

Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma
por: Han, Jiayi, et al.
Publicado: (2020)

Regulation of miRNA-mediated gene silencing by miRNA precursors
por: Roy-Chaudhuri, Biswajoy, et al.
Publicado: (2014)

MiRNA-128 and MiRNA-142 Regulate Tumorigenesis and EMT in Oral Squamous Cell Carcinoma Through HOXA10
por: Yao, Yao, et al.
Publicado: (2020)

ATLAS computing on CSCS HPC
por: Filipcic, Andrej, et al.
Publicado: (2015)

ATLAS computing on CSCS HPC
por: Hostettler, Michael Artur, et al.
Publicado: (2015)

Identification of chemoresistance-associated miRNAs in breast cancer
por: Lou, Weiyang, et al.
Publicado: (2018)

Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2021)

Advances and perspectives of PARP inhibitors
por: Yi, Ming, et al.
Publicado: (2019)

EMT is not required for lung metastasis but contributes to chemoresistance
por: Fischer, Kari R., et al.
Publicado: (2015)

CSCs: regenerating optimism for osteosarcoma treatment
por: Levin, Adam S.
Publicado: (2018)

ALDH1A3 in CSCs
por: Sullivan, Kelly E., et al.
Publicado: (2017)

Eradication of CSCs: the roadmap for curing cancer
por: Romano, Simona, et al.
Publicado: (2020)

Construction of miRNA‐lncRNA‐mRNA co‐expression network affecting EMT‐mediated cisplatin resistance in ovarian cancer
por: Naghsh‐Nilchi, Amirhosein, et al.
Publicado: (2022)

Deciphering the role of microRNA 21 in cancer stem cells (CSCs)
por: Sekar, Durairaj, et al.
Publicado: (2016)

miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer
por: Cai, Zhonglin, et al.
Publicado: (2019)

Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
por: Singh, Shivam, et al.
Publicado: (2023)

CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
por: Sulaiman, Andrew, et al.
Publicado: (2019)

miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin
por: Chen, Xuesong, et al.
Publicado: (2016)

Transition to resistance: An unexpected role of the EMT in cancer chemoresistance
por: Wang, Jing, et al.
Publicado: (2016)

Impact of miRNA Sequence on miRNA Expression and Correlation between miRNA Expression and Cell Cycle Regulation in Breast Cancer Cells
por: Luo, Zijun, et al.
Publicado: (2014)

Regulation of miRNA Processing and miRNA Mediated Gene Repression in Cancer
por: Bajan, Sarah, et al.
Publicado: (2014)

Deciphering miRNA–Target Relationships to Understand miRNA-Mediated Carcinogenesis
por: Navarro, Alfons
Publicado: (2021)

EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer
por: Zheng, Xiaofeng, et al.
Publicado: (2015)

Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS)
por: Leng, Xiaoling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1d1p9hn6bkndo5jp41sk1ms1es